Status:
WITHDRAWN
Evaluating Effects of Curcumin in Moderate to Severe Asthmatics
Lead Sponsor:
Loma Linda University
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this investigator-initiated study is to evaluate the effects of oral curcumin supplementation versus placebo in adult patients with moderate to severe asthma. Curcumin, a derivative of ...
Eligibility Criteria
Inclusion
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged 18 and older
- Physician diagnosed moderate to severe asthma: (GINA 2018)
- a. Stable asthma that requires ICS/LABA and/or an additional controller agent (i.e. LTRA, LAMA)
- Ability to take oral medication and be willing to adhere to the regimen
- Ability to speak and read English
- If female and sexually active, should use effective forms of birth control
Exclusion
- Current use of turmeric (curcumin) or use within the last 7 days
- Current use of biologic therapy/ immunotherapy/ or bronchothermoplasty
- Pregnancy or lactation
- Known allergic reactions to components of turmeric (curcumin)
- Current use of anticoagulants, and history of coagulopathy or liver disease
- INR greater than 2.0, PTT greater than 45.0 seconds
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 9 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04353310
Start Date
September 1 2021
End Date
November 9 2021
Last Update
November 17 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.